A
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Price:
18.17
CNY
-2.05%
Market Closed
Market Cap:
¥21B
Relative Value
The Relative Value of one Apeloa Pharmaceutical Co Ltd stock under the Base Case scenario is 16.45 CNY. Compared to the current market price of 18.17 CNY, Apeloa Pharmaceutical Co Ltd is Overvalued by 9%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
16.45
CNY
Overvaluation 9%
A
Multiples Across Competitors
Competitors Multiples
Apeloa Pharmaceutical Co Ltd Competitors
Apeloa Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
A
|
Apeloa Pharmaceutical Co Ltd
SZSE:000739
|
21B CNY | 2 | 24.4 | 21.4 | 21.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
960.4B USD | 14.8 | 46.7 | 31.5 | 33.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
591.5B USD | 6.3 | 22.1 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.5B CHF | 4.8 | 31 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.4B GBP | 5.5 | 31.6 | 17.4 | 24.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
242.5B CHF | 5.5 | 22.3 | 13.8 | 17.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302.2B USD | 4.7 | 16.6 | 10.4 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.7 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.5 | 7.3 | 9.8 | |
| UK |
|
GSK plc
XETRA:GS71
|
105.9B EUR | 2.8 | 16.1 | 8.1 | 11.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
